These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29375578)

  • 1. An Explorative Biomarker Study for Vaccine Responsiveness after a Primary Meningococcal Vaccination in Middle-Aged Adults.
    van der Heiden M; Berbers GAM; Fuentes S; van Zelm MC; Boots AMH; Buisman AM
    Front Immunol; 2017; 8():1962. PubMed ID: 29375578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Intervention in the Aging Population: A Primary Meningococcal Vaccine Inducing Protective IgM Responses in Middle-Aged Adults.
    van der Heiden M; Boots AMH; Bonacic Marinovic AA; de Rond LGH; van Maurik M; Tcherniaeva I; Berbers GAM; Buisman AM
    Front Immunol; 2017; 8():817. PubMed ID: 28769927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower antibody functionality in middle-aged adults compared to adolescents after primary meningococcal vaccination: Role of IgM.
    van der Heiden M; van Ravenhorst MB; Bogaard M; Boots AMH; Berbers GAM; Buisman AM
    Exp Gerontol; 2018 May; 105():101-108. PubMed ID: 29287771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and safety of a quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) administered to adults aged 56 Years and older: results of an open-label, randomized, controlled trial.
    Dbaibo G; El-Ayoubi N; Ghanem S; Hajar F; Bianco V; Miller JM; Mesaros N
    Drugs Aging; 2013 May; 30(5):309-19. PubMed ID: 23494214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling differences in peripheral blood mononuclear cells of high and low vaccine responders prior to, and following, vaccination in piglets.
    Lipsit S; Facciuolo A; Scruten E; Wilkinson J; Plastow G; Kusalik A; Napper S
    Vaccine X; 2022 Aug; 11():100167. PubMed ID: 35692279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired Immune Response to Primary but Not to Booster Vaccination Against Hepatitis B in Older Adults.
    Weinberger B; Haks MC; de Paus RA; Ottenhoff THM; Bauer T; Grubeck-Loebenstein B
    Front Immunol; 2018; 9():1035. PubMed ID: 29868000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin E, vitamin A, and zinc status are not related to serologic response to influenza vaccine in older adults: an observational prospective cohort study.
    Sundaram ME; Meydani SN; Vandermause M; Shay DK; Coleman LA
    Nutr Res; 2014 Feb; 34(2):149-54. PubMed ID: 24461316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults.
    van der Heiden M; de Rond LGH; van Zelm MC; Berbers GAM; Boots AMH; Buisman AM
    Front Immunol; 2018; 9():46. PubMed ID: 29410671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.
    Powell AM; Luo Z; Martin L; Wan Z; Ma L; Liao G; Song Y; Li X; Michael Kilby J; Huang L; Jiang W
    Vaccine; 2017 Feb; 35(5):831-841. PubMed ID: 28017428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B Vaccine Non-Responders Show Higher Frequencies of CD24
    Körber N; Pohl L; Weinberger B; Grubeck-Loebenstein B; Wawer A; Knolle PA; Roggendorf H; Protzer U; Bauer T
    Front Immunol; 2021; 12():713351. PubMed ID: 34566969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Cytokines and Birth Weight as Biomarkers of Vaccine-Induced Humoral Responses in Piglets.
    Lipsit S; Facciuolo A; Scruten E; Griebel P; Napper S
    Front Vet Sci; 2022; 9():922992. PubMed ID: 35903142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness to Influenza Vaccination Correlates with NKG2C-Expression on NK Cells.
    Riese P; Trittel S; Pathirana RD; Klawonn F; Cox RJ; Guzmán CA
    Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32517137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of
    de Armas LR; Cotugno N; Pallikkuth S; Pan L; Rinaldi S; Sanchez MC; Gonzalez L; Cagigi A; Rossi P; Palma P; Pahwa S
    J Immunol; 2017 Mar; 198(5):1995-2005. PubMed ID: 28130496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study.
    Chen WH; Neuzil KM; Boyce CR; Pasetti MF; Reymann MK; Martellet L; Hosken N; LaForce FM; Dhere RM; Pisal SS; Chaudhari A; Kulkarni PS; Borrow R; Findlow H; Brown V; McDonough ML; Dally L; Alderson MR
    Lancet Infect Dis; 2018 Oct; 18(10):1088-1096. PubMed ID: 30120069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of a meningococcal quadrivalent conjugate vaccine in Saudi Arabian adolescents previously vaccinated with one dose of bivalent and quadrivalent meningococcal polysaccharide vaccines: a phase III, controlled, randomized, and modified blind-observer study.
    Al-Mazrou Y; Khalil M; Findlow H; Chadha H; Bosch Castells V; Johnson DR; Borrow R
    Clin Vaccine Immunol; 2012 Jul; 19(7):999-1004. PubMed ID: 22552602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine.
    Krawczyk A; Ludwig C; Jochum C; Fiedler M; Heinemann FM; Shouval D; Roggendorf M; Roggendorf H; Lindemann M
    Vaccine; 2014 Sep; 32(39):5077-82. PubMed ID: 24975813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinome profiling of peripheral blood mononuclear cells collected prior to vaccination reveals biomarkers and potential mechanisms of vaccine unresponsiveness in pigs.
    Lipsit SWL; Wilkinson J; Scruten E; Facciuolo A; Denomy C; Griebel PJ; Kusalik A; Plastow G; Napper S
    Sci Rep; 2020 Jul; 10(1):11546. PubMed ID: 32665671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of pre-existing antibody on subsequent immune responses to meningococcal A-containing vaccines.
    Idoko OT; Okolo SN; Plikaytis B; Akinsola A; Viviani S; Borrow R; Carlone G; Findlow H; Elie C; Kulkarni PS; Preziosi MP; Ota M; Kampmann B
    Vaccine; 2014 Jul; 32(33):4220-7. PubMed ID: 24863486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of a meningococcal quadrivalent conjugate vaccine in five- to eight-year-old Saudi Arabian children previously vaccinated with two doses of a meningococcal quadrivalent polysaccharide vaccine.
    Khalil M; Al-Mazrou Y; Findlow H; Chadha H; Bosch Castells V; Johnson DR; Borrow R
    Clin Vaccine Immunol; 2012 Oct; 19(10):1561-6. PubMed ID: 22855388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals.
    Goronzy JJ; Fulbright JW; Crowson CS; Poland GA; O'Fallon WM; Weyand CM
    J Virol; 2001 Dec; 75(24):12182-7. PubMed ID: 11711609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.